Search results
Sanofi SA's Dividend Analysis
GuruFocus.com via Yahoo Finance· 11 hours agoSanofi SA (NASDAQ:SNY) recently announced a dividend of $2.04 per share, payable on 2024-06-06, with the ex-dividend date set for 2024-05-09. As...
Sanofi's New Cancer Drug Could Help Deliver a Big Payday
Motley Fool via Yahoo Finance· 8 hours agoNow looks like an excellent time to start a position in the stock. Should you invest $1,000 in ...
Inhibrx, Inc. Announces Record Date and Expected Distribution Time for Anticipated Spin-Off and the...
WFRV 5 Green Bay· 2 hours agoBiosciences, Inc. ("SpinCo"), to holders of shares of the Company's common stock on a pro rata basis (the "Spin-Off"). The Company also announced that the distribution in ...
Teva Pharma's Turnaround Story: How A Key Win Helped It Clinch A Five-Year High
Investor's Business Daily· 2 hours agoTeva's adjusted earnings lagged expectations by 4 cents a share. But at 48 cents a share, earnings...
Kestra Private Wealth Services LLC Sells 1,300 Shares of Sanofi (NASDAQ:SNY)
ETF DAILY NEWS· 5 days agoKestra Private Wealth Services LLC decreased its stake in shares of Sanofi (NASDAQ:SNY – Free Report) by 5.5% during the fourth quarter, according to its most recent filing ...
Denali (DNLI) Q1 Earnings Miss, Pipeline Progress in Focus
Zacks via Yahoo Finance· 10 hours agoSanofi is currently conducting a phase II study of the UC treatment candidate. Zacks Rank and A ...
European Stocks Close Higher Again On Earnings, Rate Cut Hopes
RTT News· 6 hours agoEuropean stocks closed higher on Wednesday, turned in another positive performance after recent gains amid rising optimism about interest rate cuts by central banks in the second or third quarter of this year.
3 Biotech Stocks to Buy and Hold Through 2030 and Beyond
Motley Fool via Yahoo Finance· 6 days agoSanofi predicts peak sales between 2 billion euros and 5 billion euros ($2.14 billion to $5.35...
Arkema And Two More High-Yield Dividend Stocks To Consider
Simply Wall St. via Yahoo Finance· 15 hours agoAs the French market navigates a period of recovery, with the CAC 40 Index recently experiencing a...
Regeneron Reverses On Better-Than-Feared Eylea Sales As Patent Expiration Looms
Investor's Business Daily· 6 days agoOverall, revenue ticked down 1% to $3.15 billion, missing forecasts for $3.23 billion, according to...
